Latest News

Oncology tests surged 176% while prenatal revenue climbed 55%, driving 64% overall growth.

CEO Vanderkooy discusses $440M Ravenswood acquisition and upward guidance revisions.

CEO Gupta discusses capital return guidance hike and new AI underwriting tool.

Net leverage fell 35% as pricing strength lifted Plant Nutrition margins.

Record earnings fueled by smartphone demand and expanded mixed-signal content across new markets.

Record client assets hit $346.1 billion as net inflows surge on diversified product momentum.

Company posts first positive EBITDA and adjusted net income in its history.

LIVMARLI sales surged 46% while management raised full-year guidance to $680M–$700M.

Datacenter revenue surged 103% sequentially as $93.9B in long-term agreements secure AI demand.

Journey Medical reported higher second-quarter revenue and improved profitability, driven by continued prescription growth and improving payer reimbursement for its rosacea treatment Emrosi. Chief Executive Officer Claude Maraoui said the company generated positive EBITDA in the second quarter and

CuriosityStream (NASDAQ:CURI) reported what Chief Executive Officer Clint Stinchcomb described as the strongest quarterly financial performance in the company’s history for the second quarter of 2026, driven by growth in licensing revenue, lower operating expenses and improved margins. Revenue tota

Journey Medical (NASDAQ:DERM) reported higher second-quarter revenue and a sharply narrower net loss as sales of its rosacea treatment EMROSI continued to grow, supported by rising prescription volume, broader prescriber adoption and improving payer reimbursement. Total revenue for the second quart

Enovix (NASDAQ:ENVX) reported second-quarter 2026 revenue at the high end of its guidance and highlighted progress in smartphone battery qualification, an initial commercial ramp in smart eyewear, and expanding drone and defense opportunities. Revenue for the quarter was $9 million, up 21% from a y

Allot (NASDAQ:ALLT) reported second-quarter 2026 revenue growth, improved profitability and stronger operating cash flow, supported by continued expansion of its Security-as-a-Service, or SECaaS, business and a sharp increase in North American sales. Revenue for the quarter totaled $27.7 million, u

Elon Musk just told SpaceX employees that AI will soon out-earn rockets and Starlink combined -- but investors should weigh the bold vision against some serious execution risks.

Environmental waste treatment and services provider Perma-Fix (NASDAQ:PESI) met Wall Street’s revenue expectations in Q2 CY2026, but sales fell by 11.7% year...

The disposition cuts the insider's direct holdings nearly in half.

Blue Creek mine ramp-up drove record sales volumes and $103.4 million in free cash flow.

Record revenue and operating cash flow signal strong execution.

A Phillips 66 insider exercised options and immediately liquidated shares at an average price of $210.78.

Real estate proceeds fund $2.1B insurance acquisition as diversification strategy takes shape.

Enact mortgage insurance drove $143 million adjusted operating income in the quarter.

Record automotive demand and AI infrastructure growth drive 22% revenue increase.

RevPAR surged 5.3% as business travel recovered and margins expanded 120 basis points.

Options volume surged 25% as volatility boosted net revenue to $141.1 million.